Accolade To Present at Upcoming Investor Conferences

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

SEATTLE, Jan. 02, 2024 (GLOBE NEWSWIRE) — Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the following upcoming investor conferences:

  • 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 11 at 7:30am PT
  • 26th Annual Needham Growth Conference in New York on Thursday, January 18 at 3:00pm ET

A webcast of these events will be available at ir.accolade.com and a replay will be available for 90 days.

About Accolade, Inc.

Accolade (Nasdaq: ACCD) is a Personalized Healthcare company that provides millions of people and their families with exceptional healthcare experiences so they can live their healthiest lives. Accolade’s employer, health plan, and consumer solutions combine virtual primary care and mental health, expert medical opinion, and best-in-class care navigation. These offerings are built on a platform that is engineered to care through predictive engagement of population health needs, proactive care that improves outcomes and cost savings, and by addressing barriers to access and continuity of care. Accolade consistently receives consumer satisfaction ratings of over 90%. For more information, visit accolade.com. Follow us on LinkedInTwitter, Instagram and Facebook.

Investor Contact:

Todd Friedman, Investor Relations, IR@accolade.com

Source: Accolade        

Staff

Recent Posts

UPDATE — Relmada Therapeutics To Present NDV-01 Data at AUA2025

Data to be presented in Clinical Trials in Progress Session on Monday, April 28, 2025CORAL…

15 hours ago

2025 (Spring) Pharmaceutical Machinery Exposition Concludes Successfully

BEIJING, April 27, 2025 (GLOBE NEWSWIRE) -- On April 25, 2025, the 66th (Spring 2025)…

15 hours ago

Best Legal Steroids For Muscle Growth: Top Anabolic Steroids Alternatives For (Bulking & Bodybuilding) That Really Work – By Crazy Bulk

After six months of research on the ingredients and thousands of feedback from real consumers,…

15 hours ago

Three-Year Data of Zenflow’s Spring System Demonstrate Durability of Clinical Benefits for Patients Suffering from BPH

Data Presented at the AUA Meeting Reflect Longest-Term Data among FIT InterventionsSOUTH SAN FRANCISCO, Calif.,…

15 hours ago